Aim: The objective of the present study was to design, synthesize and evaluate diverse Schiff bases and thiazolidin-4-one derivatives of aminothiazole as key pharmacophores possessing acetylcholinesterase inhibitory activity. Materials & methods: Two series of compounds (13 each) were synthesized and evaluated for their acetylcholinesterase inhibition and antioxidant activity. Molecular docking of all compounds was performed to provide an insight into their binding interactions. Results: Compounds 2j (IC₅₀ = 0.03 μM) and 3e (IC₅₀ = 1.58 μM) were found to be the best acetylcholinesterase inhibitors among compounds of their respective series. Molecular docking analysis supported the results of in vitro activity by displaying good docking scores with the binding pocket of human acetylcholinesterase (Protein Data Bank ID: 4EY7). Conclusion: Compound 2j emerged as a potential lead compound with excellent acetylcholinesterase inhibition, antioxidant and chelation activity.

Graphical abstract

Keywords:

Papers of special note have been highlighted as: • of interest

References

1. Fang J, Li Y, Liu R et al. Discovery of multitarget-directed ligands against Alzheimer’s disease through systematic prediction of chemical–protein interactions. J. Chem. Inf. Model. 55(1), 149–164 (2015).
Medline CASGoogle Scholar
2. Cao J, Hou J, Ping J, Cai D. Advances in developing novel therapeutic strategies for Alzheimer’s disease. Mol. Neurodegener. 13(1), 64 (2018).
Medline CASGoogle Scholar
3. Sun BL, Li WW, Zhu C et al. Clinical research on Alzheimer’s disease: progress and perspectives. Neurosci. Bull. 34, 1111–1118 (2018).
Medline CASGoogle Scholar
4. Guo YY, Yang LZ, Ru JX et al. An ‘OFF–ON’ fluorescent chemosensor for highly selective and sensitive detection of Al (III) in aqueous solution. Dyes Pigm. 99(3), 693–698 (2013).
CASGoogle Scholar
5. Zhang P, Xu S, Zhu Z, Xu J. Multi-target design strategies for the improved treatment of Alzheimer’s disease. Eur. J. Med. Chem. 176, 228–247 (2019).
Medline CASGoogle Scholar
6. de Freitas Silva M, Dias KS, Gontijo VS, Ortiz CJ, Viegas C Jr. Multi-target directed drugs as a modern approach for drug design towards Alzheimer’s disease: an update. Curr. Med. Chem. 25(29), 3491–3525 (2018).
MedlineGoogle Scholar
7. Huang LK, Chao SP, Hu CJ. Clinical trials of new drugs for Alzheimer disease. J. Biomed. Sci. 27(1), 18 (2020).
Medline CASGoogle Scholar
8. Marucci G, Buccioni M, Dal Ben D, Lambertucci C, Volpini R, Amenta F. Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology 190, 108352 (2021).
Medline CASGoogle Scholar
9. Campbell A. The potential role of aluminium in Alzheimer’s disease. Nephrol. Dial. Transplant. 17(2), 17–20 (2002).
Medline CASGoogle Scholar
10. Bondy SC, Kirstein S. The promotion of iron-induced generation of reactive oxygen species in nerve tissue by aluminum. Mol. Chem. Neuropathol. 27, 185–194 (1996).
Medline CASGoogle Scholar
11. Vecchio I, Sorrentino L, Paoletti A, Marra R, Arbitrio M. The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease. J. Cent. Nerv. Syst. Dis. 13, 11795735211029113 (2021).
Google Scholar
12. Shi L, Mao WJ, Yang Y, Zhu HL. Synthesis, characterization, and biological activity of a Schiff-base Zn (II) complex. J. Coord. Chem. 62(21), 3471–3477 (2009).
CASGoogle Scholar
13. Zhao J, Zhao B, Liu J, Xu W, Wang Z. Spectroscopy study on the photochromism of Schiff bases N,N'-bis (salicylidene)-1,2-diaminoethane and N,N'-bis (salicylidene)-1,6-hexanediamine. Spectrochim. Acta A Mol. Biomol. Spectrosc. 57(1), 149–154 (2001).
Medline CASGoogle Scholar
14. Shanty AA, Philip JE, Sneha EJ, Kurup MR, Balachandran S, Mohanan PV. Synthesis, characterization and biological studies of Schiff bases derived from heterocyclic moiety. Bioorg. Chem. 70, 67–73 (2017).
Medline CASGoogle Scholar
15. Desai SB, Desai PB, Desai KR. Synthesis of some Schiff bases, thiazolidinones and azetidinones derived from 2,6-diaminobenzo [1,2-d:4,5-d’]bisthiazole and their anticancer activities. Heterocycl. Commun. 7(1), 83–90 (2001).
CASGoogle Scholar
16. Pandeya SN, Sriram D, Nath G, DeClercq E. Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4′-chlorophenyl)thiazol-2-yl]thiosemicarbazide. Eur. J. Pharm. Sci. 9(1), 25–31 (1999).
Medline CASGoogle Scholar
17. Jadhao M, Das C, Rawat A et al. Development of multifunctional heterocyclic Schiff base as a potential metal chelator: a comprehensive spectroscopic approach towards drug discovery. J. Biol. Inorg. Chem. 22, 47–59 (2017).
Medline CASGoogle Scholar
18. Abd Razik MB, Osman H, Ezzat OM et al. Efficient synthesis and discovery of Schiff bases as potent cholinesterase inhibitors. Med. Chem. 12(6), 527–536 (2016).
MedlineGoogle Scholar
19. Kavitha CV, Swamy SN, Mantelingu K et al. Synthesis of new bioactive venlafaxine analogs: novel thiazolidin-4-ones as antimicrobials. Bioorg. Med. Chem. 14(7), 2290–2299 (2006).
Medline CASGoogle Scholar
20. Omar K, Geronikaki A, Zoumpoulakis P et al. Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs. Bioorg. Med. Chem. 18(1), 426–432 (2010).
Medline CASGoogle Scholar
21. Isloor AM, Sunil D, Shetty P, Malladi S, Pai KS, Maliyakkl N. Synthesis, characterization, anticancer, and antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells. Med. Chem. Res. 22, 758–767 (2013).
CASGoogle Scholar
22. Ottanà R, Maccari R, Ciurleo R et al. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors. Bioorg. Med. Chem. 17(5), 1928–1937 (2009).
Medline CASGoogle Scholar
23. Nofal ZM, Soliman EA, Abd El-Karim SS et al. Synthesis of some new benzimidazole-thiazole derivatives as anticancer agents. J. Heterocycl. Chem. 51(6), 1797–1806 (2014).
CASGoogle Scholar
24. Taslimi P, Osmanova S, Gulçin İ et al. Discovery of potent carbonic anhydrase, acetylcholinesterase, and butyrylcholinesterase enzymes inhibitors: the new amides and thiazolin-4-ones synthesized on an acetophenone base. J. Biochem. Mol. Toxicol. 31(9), e21931 (2017).
Google Scholar
25. Raza R, Saeed A, Arif M et al. Synthesis and biological evaluation of 3-thiazolocoumarinyl schiff-base derivatives as cholinesterase inhibitors. Chem. Biol. Drug Des. 80(4), 605–615 (2012).
Medline CASGoogle Scholar
26. Shi J, Zhou Y, Wang K et al. Design, synthesis and biological evaluation of Schiff base derivatives as multifunctional agents for the treatment of Alzheimer’s disease. Med. Chem. Res. 30, 624–634 (2021).
CASGoogle Scholar
27. Abedi-Jazini Z, Safari J, Zarnegar Z, Sadeghi M. A simple and efficient method for the synthesis of 2-aminothiazoles under mild conditions. Polycycl. Aromat. Compd 38(3), 231–235 (2018). • Articles mentioning synthetic protocol of aminothiazole, Schiff bases and thiazolin-4-one scaffold.
CASGoogle Scholar
28. Rahim F, Javed MT, Ullah H et al. Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease. Bioorg. Chem. 62, 106–116 (2015).
Medline CASGoogle Scholar
29. Hoan DQ. Reaction of Schiff bases with thioglycolic acid: synthesis of thiazepine-1(2H)-one and thiazolin-4-one compounds. Hue Univer. J. Sci. Nat. Sci. 127(1A), 5–14 (2018).
Google Scholar
30. Sharma D, Kumar S, Narasimhan B et al. 4-(4-Bromophenyl)-thiazol-2-amine derivatives: synthesis, biological activity and molecular docking study with ADME profile. BMC Chem. 13(1), 60 (2019).
MedlineGoogle Scholar
31. Dingova D, Leroy J, Check A, Garaj V, Krejci E, Hrabovska A. Optimal detection of cholinesterase activity in biological samples: modifications to the standard Ellman’s assay. Anal. Biochem. 462, 67–75 (2014).
Medline CASGoogle Scholar
32. Magalhães LM, Segundo MA, Reis S, Lima JL. Automatic method for determination of total antioxidant capacity using 2,2-diphenyl-1-picrylhydrazyl assay. Anal. Chim. Acta 558(1–2), 310–318 (2006).
CASGoogle Scholar
33. Elmastaş M, Gülçin I, Beydemir Ş, İrfan Küfrevioğlu Ö, Aboul-Enein HY. A study on the in vitro antioxidant activity of juniper (Juniperus communis L.) fruit extracts. Anal. Lett. 39(1), 47–65 (2006).
CASGoogle Scholar
34. Gupta VK, Singh AK, Kumawat LK. Thiazole Schiff base turn-on fluorescent chemosensor for Al³⁺ ion. Sens. Actuat. B Chem. 195, 98–108 (2014).
CASGoogle Scholar
35. Schrödinger Release 2018-3: Glide. Schrödinger, LLC, NY, USA (2018).
Google Scholar
36. Friesner RA, Murphy RB, Repasky MP et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes. J. Med. Chem. 49(21), 6177–6196 (2006).
Medline CASGoogle Scholar
37. Schrödinger Release 2018-3: LigPrep. Schrödinger, LLC, NY, USA (2018).
Google Scholar
38. Wang Y, Xing J, Xu Y et al. In silico ADME/T modelling for rational drug design. Q. Rev. Biophys. 48(4), 488–515 (2015).
MedlineGoogle Scholar
39. Clark DE. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J. Pharm. Sci. 88(8), 807–814 (1999).
Medline CASGoogle Scholar
40. Kelder J, Grootenhuis PD, Bayada DM, Delbressine LP, Ploemen JP. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm. Res. 16, 1514–1519 (1999).
Medline CASGoogle Scholar
41. Almeida H, Vieira AC, Teixeira J et al. Cell-based intestinal in vitro models for drug absorption screening. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Springer International Publishing, Cham, 1–22 (2022).
Google Scholar
42. Irvine JD, Takahashi L, Lockhart K et al. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J. Pharm. Sci. 88(1), 28–33 (1999).
Medline CASGoogle Scholar
43. Ma XL, Chen C, Yang J. Predictive model of blood–brain barrier penetration of organic compounds. Acta Pharmacol. Sin. 26(4), 500–512 (2005).
Medline CASGoogle Scholar
44. Bekker H, Berendsen HJ, Dijkstra EJ et al. GROMACS–a parallel computer for molecular-dynamics simulations. Presented at: 4th International Conference on Computational Physics (PC 92). World Scientific Publishing, 252–256, 24–28 August (1992). • Articles discussing significance of molecular dynamic simulation.
Google Scholar
45. Ganesan A, Coote ML, Barakat K. Molecular dynamics-driven drug discovery: leaping forward with confidence. Drug Discov. Today 22(2), 249–269 (2017).
Medline CASGoogle Scholar
46. Schmid N, Eichenberger AP, Choutko A et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 40, 843–856 (2011).
Medline CASGoogle Scholar
47. Van Aalten DM, Bywater R, Findlay JB, Hendlich M, Hooft RW, Vriend G. PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J. Comput. Aided Mol. Des. 10, 255–262 (1996).
Medline CASGoogle Scholar
48. Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J. Phys Chem. A 105(43), 9954–9960 (2001).
CASGoogle Scholar
49. Van Gunsteren WF, Berendsen HJ. A leap-frog algorithm for stochastic dynamics. Mol. Simul. 1(3), 173–185 (1988).
Google Scholar
50. Berendsen HJ, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput. Phys Commun. 91(1–3), 43–56 (1995).
CASGoogle Scholar
51. Hess B, Bekker H, Berendsen HJ, Fraaije JG. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18(12), 1463–1472 (1997).
CASGoogle Scholar
52. Di Pierro M, Elber R, Leimkuhler B. A stochastic algorithm for the isobaric-isothermal ensemble with Ewald summations for all long range forces. J. Chem. Theory Comput. 11(12), 5624–5637 (2015).
MedlineGoogle Scholar
53. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 14(1), 33–38 (1996).
Medline CASGoogle Scholar
54. Rawat R, Kant K, Kumar A, Bhati K, Verma SM. HeroMDAnalysis: an automagical tool for GROMACS-based molecular dynamics simulation analysis. Future Med. Chem. 13(05), 447–456 (2021).
CASGoogle Scholar
55. Vaught A. Graphing with Gnuplot and Xmgr: two graphing packages available under linux. Linux J. (28es), 7es (1996).
Google Scholar

Vol. 16, No. 6

Supplemental Materials

Metrics

Downloaded 17 times

History

Received 8 October 2023

Accepted 26 January 2024

Published online 20 February 2024

Published in print March 2024

Information

Keywords

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.future-science.com/doi/suppl/10.4155/fmc-2023-0290

Financial disclosure

The authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

PDF download